Finance

Lists
Why is NXTG up 8,10%?
Dive Deeper
NXTG:TLV
Nextage Therapeutics Ltd
38,70 ILA
+8,10%
(+2,90) 1D
1 қаз., 14:35:00 GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for NXTG...
Open
35,80 ILA
High
40,00 ILA
Low
35,80 ILA
Mkt. cap
36,81 млн
Avg. vol.
60,58 мың
Volume
12,64 мың
52-wk high
78,00 ILA
52-wk low
27,00 ILA
EPS
-0,07 ILA
Shares outstanding
94,86 млн
No. of employees
18
Open
35,80 ILA
High
40,00 ILA
Low
35,80 ILA
Mkt. cap
36,81 млн
Avg. vol.
60,58 мың
Volume
12,64 мың
52-wk high
78,00 ILA
52-wk low
27,00 ILA
EPS
-0,07 ILA
Shares outstanding
94,86 млн
No. of employees
18
News stories
From web sources and news partners
About Nextage Therapeutics Ltd
CEO-
Employees18
Founded1982
Headquarters-
Sector-
Previous reportsAll values in ILS
Loading Previous Earnings...
Revenue
Net income
All values in ILS
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,12 млн
1,12 млн
134,00 м.
134,00 м.
Cost of goods sold
894,50 м.
894,50 м.
762,00 м.
762,00 м.
Cost of revenue
894,50 м.
894,50 м.
762,00 м.
762,00 м.
Research and development expenses
770,50 м.
770,50 м.
513,50 м.
513,50 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,17 млн
2,17 млн
2,30 млн
2,30 млн
Operating expense
2,94 млн
2,94 млн
2,81 млн
2,81 млн
Total operating expenses
3,83 млн
3,83 млн
3,57 млн
3,57 млн
Operating income
-2,71 млн
-2,71 млн
-3,44 млн
-3,44 млн
Other non operating income
-694,00 м.
-694,00 м.
-
-
EBT including unusual items
-3,71 млн
-3,71 млн
-4,28 млн
-4,28 млн
EBT excluding unusual items
-3,71 млн
-3,71 млн
-4,28 млн
-4,28 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,71 млн
-3,71 млн
-4,21 млн
-4,21 млн
Net profit margin
-330,57%
-330,57%
-3 143,66%
-3 143,66%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-162,50 м.
-162,50 м.
-837,00 м.
-837,00 м.
Net interest expenses
-162,50 м.
-162,50 м.
-837,00 м.
-837,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,52 млн
-2,59 млн
-3,12 млн
-3,12 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары